NHS weight-loss jabs are set to become available in pharmacies over the coming years as part of a plan to boost the nation’s ...

NHS leaders consider phased roll out of Mounjaro obesity jab to combat high demand - Nearly a quarter of a million people are expected to receive the Mounjaro jab over the next three years.

The NHS has been slammed for saying fat people are 'living with overweight' Credit: Getty NHS weight advice says: “Living with overweight and obesity can affect your quality of life.”. And a ...

'Obesity is the new smoking', NHS chief to say. Being overweight is the second biggest cause of cancer. Alex Matthews-King. Health Correspondent. Wednesday 14 March 2018 01:20 GMT. Comments.

The type 2 diabetes drug Mounjaro has been recommended to help obese people lose weight on the NHS. Mounjaro – also known as tirzepatide and made by Eli Lilly – is a glucagon-like peptide-1 ...

Obesity levels among children due to the pandemic ‘could end up costing more than £8bn’ The new study shows obesity skyrocketed amongst children aged four to five and 10 to 11 at the height ...

More than 200 doctors and specialists have now written to the health secretary to say how stretched NHS obesity treatment services face unprecedented demand from patients wanting these drugs.

However, a record number of overweight pensioners — 28,042 — were also given new hips and knees on the NHS since 2019. Among children, figures from 2023 show 24 per cent of four and five-year ...

NHS Digital data for England shows there were a record 1.2million hospitalisations where obesity was a factor in 2022/23, double the 617,000 logged in 2016/17.

The amount of NHS hospital treatment for obese patients has quadrupled in a decade, new statistics show.. Official figures show almost 1.9 million hospital episodes of treatment for patients with ...